3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Bone Cysts: new trials by email Literature Review of Bone Cysts trials Research Report on Bone Cysts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Recurrent Basal Cell Carcinoma | Phase 2 | Terminated | Sol-Gel Technologies, Ltd. | 50 | 2019-12-20 | 2026-07-21 |
| Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Buparlisib, Sonidegib - Carcinoma, Basal Cell, Recurrent Skin Cancer | Phase 2 | Terminated | Anne Chang | 10 | 2015-02-01 | 2019-01-29 |
| LDE225 for Patients With PTCH1 or SMO Mutated Tumors LDE225 - PTCH1 or SMO Activated Solid and Hematologic Tumors | Phase 2 | Terminated | Novartis Pharmaceuticals | 10 | 2014-02-01 | 2016-05-02 |
Basal Cell Nevus Syndrome (3) · Carcinoma, Basal Cell (2) · Colonic Neoplasms (1) · Endometrial Neoplasms (1) · Hematologic Neoplasms (1) · Rombo syndrome (1) · Skin Neoplasms (1) · Syndrome (1) · Xeroderma Pigmentosum (1)
Abnormalities, Multiple (3) · Bone Diseases (3) · Bone Diseases, Developmental (3) · Carcinoma (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Cysts (3) · Genetic Diseases, Inborn (3) · Jaw Cysts (3) · Jaw Diseases (3) · Musculoskeletal Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Basal Cell (3)
sonidegib (2) · NVP-BKM120 (1)
Anne Chang (1) · Novartis Pharmaceuticals (1) · Sol-Gel Technologies, Ltd. (1)
United States (3)